MRG003 Clinical Trials
4 recruitingDrug
Phase 23Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 2
Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma
Hepato Cellular Carcinoma (HCC)
Fudan University40 enrolled1 locationNCT07536789
Recruiting
Phase 2
Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck
Locally Advanced Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou106 enrolled1 locationNCT06959108
Recruiting
Phase 1
MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma
Penile Cancer
Jiyan Liu10 enrolled1 locationNCT07054307
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Shanghai Miracogen Inc.116 enrolled1 locationNCT04868162